Biocompatible magnetic nanoparticles with high magnetic moment for cancer treatment

ORAL

Abstract

Non-toxic iron oxide naoparticles have extended the boundary in medical world; with size range form 2 to 400 nm they can be compiled with most of the small cells and tissues in living body. We have prepared monodispersive iron-iron oxide core-shell nanoparticles in our novel cluster deposition system. The nanoparticles have very high magnetic moment up to 200 emu/g. To test the nontoxicity and uptake we incubated the nanoparticles coated with dextrin and non-coated iron naoparticles with LXI SCLC lung cancer cells found in rats. Results indicate that both coated and noncoated cells were successfully untaken by the cells indicating that the core-shell nanoparticles are not toxic. Due to the high magnetic moment offered by the nanoparticles we propose that even in low applied external alternating field desired temperature can be reached for hyperthermia treatment in comparison to the commercially available iron oxide nanoparticles (magnetic moment less than 20 emu/g). We also found that our ferromagnetic nanoparticles were uptaken by the cancer cells without adding protamine sulfate, which is normally needed to prevent the coagulation of cells for the commercial nanoparticles.

Authors

  • Amit Sharma

    University of Idaho

  • You Qiang

    University of Idaho

  • Leslie Muldoon

    Oregon Health and Science University

  • Daniel Meyer

    University of Idaho

  • Jamie Hass

    University of Idaho